Voyager Therapeutics (VYGR) Net Income: 2015-2025
Historic Net Income for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -$27.9 million.
- Voyager Therapeutics' Net Income fell 208.40% to -$27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$126.8 million, marking a year-over-year decrease of 589.88%. This contributed to the annual value of -$65.0 million for FY2024, which is 149.12% down from last year.
- Latest data reveals that Voyager Therapeutics reported Net Income of -$27.9 million as of Q3 2025, which was up 16.45% from -$33.4 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Net Income ranged from a high of $124.0 million in Q1 2023 and a low of -$34.5 million during Q4 2024.
- Its 3-year average for Net Income is -$2.3 million, with a median of -$22.2 million in 2023.
- As far as peak fluctuations go, Voyager Therapeutics' Net Income plummeted by 566.69% in 2022, and later skyrocketed by 681.85% in 2023.
- Over the past 5 years, Voyager Therapeutics' Net Income (Quarterly) stood at $5.1 million in 2021, then crashed by 566.69% to -$23.6 million in 2022, then skyrocketed by 338.86% to $56.4 million in 2023, then slumped by 161.15% to -$34.5 million in 2024, then crashed by 208.40% to -$27.9 million in 2025.
- Its Net Income stands at -$27.9 million for Q3 2025, versus -$33.4 million for Q2 2025 and -$31.0 million for Q1 2025.